AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026)
AtaiBeckley (ATAI) reported Net Cash Flow of -$31.1 million for Q3 2025, down 398.95% on a YoY basis from $10.4 million in Q3 2024, and down 1001.36% sequentially from $3.4 million in Q2 2025.
AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026) Analysis & Trends
AtaiBeckley's Net Cash Flow history runs 2 years deep, the most recent figure standing at -$41.9 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 236.33% year-over-year to -$41.9 million in Q1 2026; TTM through Mar 2026 was -$11.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $57.7 million, up 422.39% from the prior year.
- Net Cash Flow slipped to -$31.1 million in Q3 2025, from $3.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $30.8 million in Q1 2025 and bottomed at -$41.9 million in Q1 2026.
- A 5-year average of -$3.5 million and a median of -$11.1 million in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow tumbled 987.68% in 2022 and jumped 763.91% in 2025, its largest moves.
- Tracing ATAI's Net Cash Flow over 5 years: stood at -$67.4 million in 2021, then jumped by 172.12% to $48.6 million in 2022, then sank by 164.26% to -$31.2 million in 2023, then surged by 43.73% to -$17.6 million in 2024, then plunged by 76.72% to -$31.1 million in 2025.
- Business Quant data shows ATAI's Net Cash Flow at -$31.1 million in Q3 2025, $3.4 million in Q2 2025, and $30.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -31.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.92 Mn |
| Mar 31, 2026 | -41.92 Mn |
| Sep 30, 2025 | -31.07 Mn |
| Sep 30, 2025 | -31.07 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Dec 31, 2024 | -17.58 Mn |
| Dec 31, 2024 | -17.58 Mn |
| Sep 30, 2024 | 10.39 Mn |
| Sep 30, 2024 | 10.39 Mn |
| Jun 30, 2024 | 399,000.00 |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | -11.10 Mn |
| Mar 31, 2024 | -11.10 Mn |
| Dec 31, 2023 | -31.25 Mn |
| Dec 31, 2023 | -31.25 Mn |